These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26420190)

  • 41. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma.
    Makino T; Yamasaki M; Takemasa I; Takeno A; Nakamura Y; Miyata H; Takiguchi S; Fujiwara Y; Matsuura N; Mori M; Doki Y
    Ann Surg Oncol; 2009 Jul; 16(7):2058-64. PubMed ID: 19408050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overweight patients operated on for cancer of the esophagus survive longer than normal-weight patients.
    Scarpa M; Cagol M; Bettini S; Alfieri R; Carraro A; Cavallin F; Trevellin E; Saadeh LM; Ruol A; Vettor R; Ancona E; Castoro C
    J Gastrointest Surg; 2013 Feb; 17(2):218-27. PubMed ID: 22972011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complications After Esophagectomy Are Associated With Extremes of Body Mass Index.
    Mitzman B; Schipper PH; Edwards MA; Kim S; Ferguson MK
    Ann Thorac Surg; 2018 Oct; 106(4):973-980. PubMed ID: 29936024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer.
    Grotenhuis BA; Wijnhoven BP; Hötte GJ; van der Stok EP; Tilanus HW; van Lanschot JJ
    World J Surg; 2010 Nov; 34(11):2621-7. PubMed ID: 20596708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The duration of systemic inflammatory response syndrome is a reliable indicator of long-term survival after curative esophagectomy for esophageal squamous cell carcinoma.
    Kubo N; Sakurai K; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Yashiro M; Maeda K; Ohira M
    Esophagus; 2021 Jul; 18(3):548-558. PubMed ID: 33591543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of preoperative weight loss on the postoperative course after esophageal cancer resection.
    van der Schaaf MK; Tilanus HW; van Lanschot JJ; Johar AM; Lagergren P; Lagergren J; Wijnhoven BP
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):490-5. PubMed ID: 24060365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of pulmonary complications following esophagectomy on long-term survival: multivariate meta-analysis and restricted mean survival time assessment.
    Manara M; Bona D; Bonavina L; Aiolfi A;
    Updates Surg; 2024 Jun; 76(3):757-767. PubMed ID: 38319522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of histology classification on pathologic treatment response and overall survival in distal esophageal cancer patients: a propensity matched analysis.
    Saeed SM; Naffouje S; Mehta R; Hoffe SE; Fontaine JP; Lauwers GY; Shah P; Frakes J; Pimiento JM
    Dis Esophagus; 2021 Aug; 34(8):. PubMed ID: 32996568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preoperative controlling nutritional status (CONUT) is useful to estimate the prognosis after esophagectomy for esophageal cancer.
    Yoshida N; Harada K; Baba Y; Kosumi K; Iwatsuki M; Kinoshita K; Nakamura K; Sakamoto Y; Miyamoto Y; Karashima R; Mima K; Sawayama H; Ohuchi M; Chikamoto A; Imamura Y; Watanabe M; Baba H
    Langenbecks Arch Surg; 2017 Mar; 402(2):333-341. PubMed ID: 28138759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation Between Intense Postoperative Inflammatory Response and Survival of Esophageal Cancer Patients Who Underwent Transthoracic Esophagectomy.
    Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Kitagawa Y
    Ann Surg Oncol; 2015 Dec; 22(13):4453-60. PubMed ID: 25893412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers.
    Otowa Y; Nakamura T; Takiguchi G; Yamamoto M; Kanaji S; Imanishi T; Oshikiri T; Suzuki S; Tanaka K; Kakeji Y
    Eur J Surg Oncol; 2016 Mar; 42(3):407-11. PubMed ID: 26733367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition.
    Steffen A; Schulze MB; Pischon T; Dietrich T; Molina E; Chirlaque MD; Barricarte A; Amiano P; Quirós JR; Tumino R; Mattiello A; Palli D; Vineis P; Agnoli C; Misirli G; Boffetta P; Kaaks R; Rohrmann S; Bueno-de-Mesquita HB; Peeters PH; May AM; Spencer EA; Allen NE; Bingham S; Tjønneland A; Halkjaer J; Overvad K; Stegger J; Manjer J; Lindkvist B; Hallmanns G; Stenling R; Lund E; Riboli E; Gonzalez CA; Boeing H
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2079-89. PubMed ID: 19567501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of CD44 and SOX2 expression is correlated with a poor prognosis in esophageal adenocarcinoma patients.
    Honing J; Pavlov KV; Meijer C; Smit JK; Boersma-van Ek W; Karrenbeld A; Burgerhof JG; Kruyt FA; Plukker JT
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S657-64. PubMed ID: 24833101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Prognostic Significance of the Geriatric Nutritional Risk Index in Patients with Esophageal Squamous Cell Carcinoma.
    Migita K; Matsumoto S; Wakatsuki K; Ito M; Kunishige T; Nakade H; Sho M
    Nutr Cancer; 2018; 70(8):1237-1245. PubMed ID: 30235009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relation of excess body weight and survival in patients with esophageal adenocarcinoma: a meta-analysis.
    Hong L; Zhang H; Zhao Q; Han Y; Yang J; Brain L
    Dis Esophagus; 2013 Aug; 26(6):623-7. PubMed ID: 23317016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma.
    Hong D; Lunagomez S; Kim EE; Lee JH; Bresalier RS; Swisher SG; Wu TT; Morris J; Liao Z; Komaki R; Ajani JA
    Cancer; 2005 Oct; 104(8):1620-6. PubMed ID: 16118804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer.
    Nishi T; Takeuchi H; Matsuda S; Ogura M; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
    World J Surg Oncol; 2015 Aug; 13():232. PubMed ID: 26231560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Residual lymph node status is an independent prognostic factor in esophageal squamous cell Carcinoma with pathologic T0 after preoperative radiotherapy.
    Wang Q; Yu S; Xiao Z; Liu X; Zhang W; Zhang X; He J; Sun K; Xu T; Feng Q; Zhou Z; Wang L; Yin W
    Radiat Oncol; 2015 Jul; 10():142. PubMed ID: 26159510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.
    Bergeron EJ; Lin J; Chang AC; Orringer MB; Reddy RM
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):765-71: Discussion 771-3. PubMed ID: 24314788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.